RecruitingACTRN12618000711213

An investigation in atrial remodelling and the risk of arrhythmias in endurance athletes

Atrial remodelling and risk of arrhythmias in endurance athletes


Sponsor

St Vincent's Institute of Medical Research

Enrollment

630 participants

Start Date

Feb 2, 2017

Study Type

Observational

Conditions

Summary

Atrial fibrillation (AF) is the most common sustained heart rhythm problem that increases the chance of stroke and heart failure and currently represents a growing socioeconomic burden in our ageing population. Amongst the established risk factors of age, hypertension and diabetes, exercise is increasingly recognised as a powerful modulator of AF risk. Low and moderate intensity exercise is an important therapy in the prevention and treatment of AF but, at the other end of the spectrum, intense endurance exercise has been associated with a 5-fold increase in AF risk. The reasons for this excess are not known but may relate to the profound atrial remodelling that occurs with endurance athletic training. The rate at which AF occurs in retired elite endurance athletes will be compared with non-athletes who are matched for health status, age and gender. We will assess the extent to which exercise-induced changes in heart shape, function and electrical properties represent a short-term or permanent process. This will be assessed by comparing three groups: (1) young athletes adapting to elite training, (2) middle-aged athletes during end of career detraining, and (3) retired athletes with more than 10 years of competition at national or international level. A group of athletes with arrhythmias will also provide a meaningful comparison group to determine which characteristics are shared amongst groups. To study the changes in heart structure and function we will use the latest echocardiographic and cardiac magnetic resonance imaging techniques. The study is being conducted by a team of researchers at St Vincent's Institute of Medical Research, the South Australian Health and Medical Institute and a research team in Belgium led by A/Professor Andre La Gerche.


Eligibility

Sex: Both males and femalesMin Age: 16 YearssMax Age: 80 Yearss

Plain Language Summary

Simplified for easier understanding

Atrial fibrillation — an irregular, often rapid heartbeat — is the most common sustained heart rhythm problem in adults, significantly raising the risk of stroke and heart failure. While moderate exercise protects the heart, decades of intense endurance training (think elite rowers, cyclists, or marathon runners) appears to increase the risk of atrial fibrillation by up to five times. Researchers suspect this is because years of hard training cause the heart's upper chambers (the atria) to gradually change shape and electrical properties in ways that can set the stage for rhythm problems. This study at St Vincent's Institute is comparing the heart structure and function of young elite athletes, retiring athletes, long-retired athletes, and non-athletes using advanced heart imaging. The goal is to understand whether the heart changes caused by intense training are permanent or whether they reverse when training stops — a question with major implications for how athletes should be counselled about long-term heart health. You may be eligible if you are a current or former elite endurance athlete (particularly rowers) aged 16 to 80, or a non-athlete matched for age and sex. Specific age windows apply to each group. People with known heart or lung conditions diagnosed before age 30, metal implants incompatible with MRI scans, or who are pregnant are not eligible. A separate but related study is also recruiting young athletes aged 16 to 23.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Testing of the participants will happen at baseline and a repeat test after 2 years. Testing includes: Echocardiography Electrocardiogram VO2 max test Blood samples Holter monitor recording for

Testing of the participants will happen at baseline and a repeat test after 2 years. Testing includes: Echocardiography Electrocardiogram VO2 max test Blood samples Holter monitor recording for 24 hours Cardiac MRI (Magnetic Resonance Imaging) Dexa scan to measure body composition and bone mineral density Anthropological measures (height and weight) 3-12 month training diary (electronic or paper copy) Health questionnaire


Locations(4)

Baker Heart and Diabetes Institute - Melbourne

SA,VIC, Australia

South Australian Health and Medical Research Institute (SAHMRI) - Adelaide

SA,VIC, Australia

St Vincent's Hospital (Melbourne) Ltd - Fitzroy

SA,VIC, Australia

Antwerp and Brabant, Belgium

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12618000711213


Related Trials